| Stage | ARXS | % of rev | WING | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $564M | 100.00% | $185M | 100.00% | ARXS ×3.05 |
| Gross profit | $306M | 54.27% | $158M | 85.30% | WING +31.0pp |
| Operating income | $133M | 23.66% | $51M | 27.38% | WING +3.7pp |
| Pre-tax income | $120M | 21.23% | $40M | 21.62% | WING +0.4pp |
| Net income | $84M | 14.84% | $29M | 15.72% | WING +0.9pp |
| Stage | ARXS | WING | Gap · A − B |
|---|---|---|---|
| Revenue | $564M100.00% | $185M100.00% | ARXS ×3.05 |
| Gross profit | 54.27%$306M | 85.30%$158M | WING +31.0pp |
| Operating income | 23.66%$133M | 27.38%$51M | WING +3.7pp |
| Pre-tax income | 21.23%$120M | 21.62%$40M | WING +0.4pp |
None
No disclosed counterparties: ARXS.
| Net income |
| 14.84%$84M |
| 15.72%$29M |
| WING +0.9pp |